Total Payments
$2,896
2024 Payments
$222.66
Companies
31
Transactions
132
Medicare Patients
1,574
Medicare Billing
$112,034

Payment Breakdown by Category

Food & Beverage$2,881 (99.5%)
Education$15.00 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,881 131 99.5%
Education $15.00 1 0.5%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $574.93 18 $0 (2024)
LEO Pharma Inc. $278.08 33 $0 (2018)
Novartis Pharmaceuticals Corporation $207.61 7 $0 (2018)
Galderma Laboratories, L.P. $201.86 6 $0 (2023)
AbbVie, Inc. $191.19 5 $0 (2018)
PFIZER INC. $180.33 5 $0 (2017)
Aqua Pharmaceuticals $164.43 9 $0 (2017)
Lilly USA, LLC $158.86 4 $0 (2024)
Celgene Corporation $143.86 9 $0 (2018)
Amgen Inc. $124.05 6 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $222.66 9 GENZYME CORPORATION ($105.94)
2023 $182.87 4 Galderma Laboratories, L.P. ($103.31)
2022 $33.41 2 GENZYME CORPORATION ($33.41)
2021 $196.34 5 GENZYME CORPORATION ($196.34)
2019 $123.69 1 UCB, Inc. ($123.69)
2018 $369.78 11 Novartis Pharmaceuticals Corporation ($130.01)
2017 $1,767 100 LEO Pharma Inc. ($265.32)

All Payment Transactions

132 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/17/2024 Lilly USA, LLC EBGLYSS (Drug) Food and Beverage In-kind items and services $15.05 General
Category: Immunology
12/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $30.95 General
Category: Immunology
10/22/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $22.44 General
Category: Dermatology
10/11/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $20.73 General
Category: Immunology
08/20/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.92 General
Category: Immunology
05/17/2024 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $22.79 General
Category: Immunology
02/20/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $15.28 General
Category: DERMATOLOGY
02/06/2024 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $17.28 General
Category: Immunology
02/05/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $43.22 General
Category: DERMATOLOGY
11/10/2023 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $29.53 General
Category: Immunology
05/24/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.05 General
Category: Immunology
03/28/2023 GENZYME CORPORATION DUPIXENT (Biological), DUPIXENT Food and Beverage In-kind items and services $31.98 General
Category: Immunology
03/16/2023 Galderma Laboratories, L.P. EPSOLAY (Drug), TWYNEO, AKLIEF Food and Beverage In-kind items and services $103.31 General
Category: ROSACEA
06/15/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $14.05 General
Category: Immunology
02/03/2022 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $19.36 General
Category: Immunology
09/30/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $12.74 General
Category: Immunology
07/16/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $24.68 General
Category: Immunology
07/02/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.89 General
Category: Immunology
06/17/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $12.04 General
Category: Immunology
06/15/2021 GENZYME CORPORATION Food and Beverage In-kind items and services $124.99 General
07/16/2019 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $123.69 General
Category: Immunology
12/06/2018 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $106.03 General
Category: DERMATOLOGY
04/10/2018 AbbVie, Inc. Food and Beverage In-kind items and services $117.07 General
03/06/2018 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $14.29 General
Category: DERMATOLOGY
02/09/2018 Almirall LLC Veltin (Drug) Food and Beverage Cash or cash equivalent $13.14 General
Category: Dermatology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 425 683 $258,014 $29,272
2022 10 417 623 $240,214 $28,838
2021 12 424 682 $249,283 $33,096
2020 8 308 548 $160,240 $20,829
Total Patients
1,574
Total Services
2,536
Medicare Billing
$112,034
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 83 99 $34,425 $8,073 23.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 85 108 $27,456 $6,752 24.6%
11102 Biopsy of related skin growth, first growth Office 2023 68 81 $107,973 $4,982 4.6%
17000 Destruction of precancer skin growth, 1 growth Office 2023 63 75 $29,100 $2,652 9.1%
17110 Destruction of skin growth, 1-14 growths Office 2023 28 29 $18,444 $1,945 10.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $7,154 $1,568 21.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 15 15 $5,370 $1,220 22.7%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 47 234 $15,912 $1,079 6.8%
11103 Biopsy of related skin growth, each additional growth Office 2023 22 28 $12,180 $1,000 8.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 64 80 $28,040 $7,284 26.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 81 97 $24,544 $6,210 25.3%
11102 Biopsy of related skin growth, first growth Office 2022 69 78 $98,982 $4,983 5.0%
17000 Destruction of precancer skin growth, 1 growth Office 2022 56 65 $25,220 $2,152 8.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $8,237 $1,794 21.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 22 22 $7,876 $1,679 21.3%
11103 Biopsy of related skin growth, each additional growth Office 2022 34 44 $19,140 $1,671 8.7%
17110 Destruction of skin growth, 1-14 growths Office 2022 20 21 $13,356 $1,550 11.6%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 43 186 $12,648 $944.56 7.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 11 13 $2,171 $571.42 26.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 58 74 $26,030 $7,124 27.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 77 99 $25,152 $6,742 26.8%
17110 Destruction of up to 14 skin growths Office 2021 33 43 $27,348 $3,086 11.3%
11102 Tangential biopsy of single skin lesion Office 2021 46 49 $62,181 $2,901 4.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 27 27 $13,647 $2,893 21.2%
17000 Destruction of skin growth Office 2021 59 73 $28,324 $2,508 8.9%

About Kathryn Kerisit, MD, MPH

Kathryn Kerisit, MD, MPH is a Student in an Organized Health Care Education/Training Program healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1336373729.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kathryn Kerisit, MD, MPH has received a total of $2,896 in payments from pharmaceutical and medical device companies, with $222.66 received in 2024. These payments were reported across 132 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,881).

As a Medicare-enrolled provider, Kerisit has provided services to 1,574 Medicare beneficiaries, totaling 2,536 services with total Medicare billing of $112,034. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

Products in Payments

  • DUPIXENT (Biological) $290.26
  • COSENTYX (Biological) $207.61
  • EUCRISA (Drug) $180.33
  • PICATO (Drug) $146.31
  • ENSTILAR (Drug) $131.77
  • Enbrel (Biological) $124.05
  • Cimzia (Drug) $123.69
  • ATOPIC DERMATITIS - DISEASE (Drug) $104.11
  • EPSOLAY (Drug) $103.31
  • Otezla (Drug) $65.17
  • Veltin (Drug) $59.90
  • SOOLANTRA (Drug) $58.53
  • VTAMA (Drug) $58.50
  • Cordran (Drug) $58.46
  • Humira (Biological) $54.13
  • Topicort (Drug) $44.68
  • EPIDUO FORTE (Drug) $40.02
  • VALCHLOR MECHLORETHAMINE (Drug) $38.09
  • TALTZ (Drug) $33.95
  • Absorica (Drug) $32.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Metairie